Novartis AG Statistics

Total Valuation

Novartis AG has a market cap or net worth of CAD 311.64 billion. The enterprise value is 347.49 billion.

Market Cap	311.64B
Enterprise Value	347.49B

Important Dates

The next estimated earnings date is Thursday, July 17, 2025.

Earnings Date	Jul 17, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-2.90%
Shares Change (QoQ)	-1.25%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.87B

Valuation Ratios

The trailing PE ratio is 16.86 and the forward PE ratio is 13.92.

PE Ratio	16.86
Forward PE	13.92
PS Ratio	4.07
PB Ratio	5.64
P/TBV Ratio	n/a
P/FCF Ratio	12.31
P/OCF Ratio	11.41
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.51, with an EV/FCF ratio of 13.73.

EV / Earnings	18.80
EV / Sales	4.41
EV / EBITDA	10.51
EV / EBIT	13.23
EV / FCF	13.73

Financial Position

The company has a current ratio of 0.79, with a Debt / Equity ratio of 0.81.

Current Ratio	0.79
Quick Ratio	0.50
Debt / Equity	0.81
Debt / EBITDA	1.40
Debt / FCF	1.78
Interest Coverage	16.83

Financial Efficiency

Return on equity (ROE) is 32.89% and return on invested capital (ROIC) is 16.23%.

Return on Equity (ROE)	32.89%
Return on Assets (ROA)	11.42%
Return on Invested Capital (ROIC)	16.23%
Return on Capital Employed (ROCE)	25.98%
Revenue Per Employee	1.01M
Profits Per Employee	243,571
Employee Count	75,883
Asset Turnover	0.55
Inventory Turnover	2.24

Taxes

In the past 12 months, Novartis AG has paid 2.96 billion in taxes.

Income Tax	2.96B
Effective Tax Rate	13.80%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	22.03
200-Day Moving Average	n/a
Relative Strength Index (RSI)	55.75
Average Volume (20 Days)	221

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novartis AG had revenue of CAD 76.50 billion and earned 18.48 billion in profits. Earnings per share was 9.17.

Revenue	76.50B
Gross Profit	57.90B
Operating Income	25.52B
Pretax Income	21.44B
Net Income	18.48B
EBITDA	31.75B
EBIT	25.52B
Earnings Per Share (EPS)	9.17

Full Income Statement

Balance Sheet

The company has 10.26 billion in cash and 44.95 billion in debt, giving a net cash position of -34.69 billion.

Cash & Cash Equivalents	10.26B
Total Debt	44.95B
Net Cash	-34.69B
Net Cash Per Share	n/a
Equity (Book Value)	55.27B
Book Value Per Share	28.15
Working Capital	-9.36B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 27.31 billion and capital expenditures -2.00 billion, giving a free cash flow of 25.31 billion.

Operating Cash Flow	27.31B
Capital Expenditures	-2.00B
Free Cash Flow	25.31B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 75.68%, with operating and profit margins of 33.35% and 24.16%.

Gross Margin	75.68%
Operating Margin	33.35%
Pretax Margin	28.03%
Profit Margin	24.16%
EBITDA Margin	41.50%
EBIT Margin	33.35%
FCF Margin	33.08%

Dividends & Yields

Novartis AG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	60.27%
Buyback Yield	2.90%
Shareholder Yield	n/a
Earnings Yield	5.93%
FCF Yield	8.12%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Novartis AG has an Altman Z-Score of 3.71 and a Piotroski F-Score of 6.

Altman Z-Score	3.71
Piotroski F-Score	6